SOFITUZUMAB
UNII 910KH73X8Q

Substance Identification & Data

This profile provides standardized clinical and technical data for Sofituzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 910KH73X8Q.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1615692-28-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

910KH73X8Q

CAS Registry Number

1615692-28-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SOFITUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C152383

National Cancer Institute reference terminology for clinical and research data.

USAN ID

CD-29

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sofituzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SOFITUZUMAB

Common Names & Synonyms

SOFITUZUMAB [USAN]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN CA 125 (CARBOHYDRATE ANTIGEN)) (HUMAN-MUS MUSCULUS MONOCLONAL MMUC1206A HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MMUC1206A LIGHT CHAIN, DIMER

SYS